|
|
 |
|
CME QUIZ |
|
Year : 2018 | Volume
: 29
| Issue : 3 | Page : 172-173 |
|
Cme test
Date of Web Publication | 27-Jun-2018 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/1879-5226.235386
How to cite this article: . Cme test. Urol Sci 2018;29:172-3 |
Please read this issue of Urological Science and return the postage-paid reply slip with your answers by June, 2018. A score of 80% or better will earn three CME credits.
- The incidence of Infectious complications (asymptomatic UTI to septic shock) after transrectal ultrasound biopsy is?
- Less than 0.1
- 1% to 4%
- 5-10%
- >10%
Urol Sci 2018;29(3):129-133.
- What is the median duration of metastatic prostate cancer treated with androgen deprivation therapy progressing to metastatic castration-resistant prostate cancer (mCRPC)?
- <10 months
- 11.7–16 months
- 24-48 months
- 48-60 months
- >60 months
Urol Sci 2018;29(3):136-144.
- What is the risk factor of urolithiasis?
- family heredity
- dietary habit
- hydration status,
- lifestyle and environmental factors
- all of the above
Urol Sci 2018;29(3):145-150.
- What is the risk of prostate cancer in the patients with atypical small acinar proliferation (ASAP)
- 20%
- 30%
- 40%
- 50%
- 60%
Urol Sci 2018;29(2):161-165.
- What is the risk of prostate cancer in the patients with high-grade prostatic intraepithelial neoplasia (HGPIN).
- 20%
- 30%
- 40%
- 50%
- 60%
Urol Sci 2018;29(2):161-165.
Volume 29 Issue 2
Answers:
1. (E) 2. (E) 3. (E) 4. (B) 5. (E) 6. (E)
|